ADVERTISEMENT
ADVERTISEMENT
Illustration of a virus
Vaccines: Sex Matters
Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.
Vaccines: Sex Matters
Vaccines: Sex Matters

Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.

Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.

adaptive immune response

Editing genome stock photo
Resolving Discrepancies in Mouse and Human Autoimmunity Studies
Niki Spahich, PhD | May 15, 2023 | 4 min read
By editing primary T cells with CRISPR, researchers begin to settle a long-standing debate about a common autoimmunity risk variant.
<em >The Scientist</em>&rsquo;s Journal Club: Immunology
The Scientist’s Journal Club: Immunology
The Scientist | May 2, 2023 | 1 min read
Scientists present the latest research on the immune response against SARS-CoV-2, the influence of COVID-19 on future vaccine responses, and drivers of T cell development.
ADVERTISEMENT